Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(antivirals). Showing records 1 – 30 of 82 total matches.

[1] [2] [3]

Search Limiters

Last 2 Years | English Only

Degrees

Languages

Country

▼ Search Limiters


Oregon State University

1. Lupfer, Christopher. Targeted development of antivirals against influenza A and respiratory syncytial virus.

Degree: PhD, Genetics, 2009, Oregon State University

 Influenza A and Respiratory Syncytial Virus (RSV) are both enveloped, negative strand RNA viruses which infect the respiratory mucosa of animals and humans. Despite decades… (more)

Subjects/Keywords: Antivirals; Influenza A virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lupfer, C. (2009). Targeted development of antivirals against influenza A and respiratory syncytial virus. (Doctoral Dissertation). Oregon State University. Retrieved from http://hdl.handle.net/1957/11948

Chicago Manual of Style (16th Edition):

Lupfer, Christopher. “Targeted development of antivirals against influenza A and respiratory syncytial virus.” 2009. Doctoral Dissertation, Oregon State University. Accessed October 19, 2019. http://hdl.handle.net/1957/11948.

MLA Handbook (7th Edition):

Lupfer, Christopher. “Targeted development of antivirals against influenza A and respiratory syncytial virus.” 2009. Web. 19 Oct 2019.

Vancouver:

Lupfer C. Targeted development of antivirals against influenza A and respiratory syncytial virus. [Internet] [Doctoral dissertation]. Oregon State University; 2009. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/1957/11948.

Council of Science Editors:

Lupfer C. Targeted development of antivirals against influenza A and respiratory syncytial virus. [Doctoral Dissertation]. Oregon State University; 2009. Available from: http://hdl.handle.net/1957/11948


University of New South Wales

2. Enosi Tuipulotu, Daniel. Norovirus antiviral discovery: host-modulators and direct-acting antivirals.

Degree: Biotechnology & Biomolecular Sciences, 2018, University of New South Wales

 Human norovirus is a leading cause of acute gastroenteritis (AGE) worldwide and is estimated to be responsible for over 200,000 deaths each year. Norovirus infections… (more)

Subjects/Keywords: Nucleoside analogue (NA); Norovirus; Antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Enosi Tuipulotu, D. (2018). Norovirus antiviral discovery: host-modulators and direct-acting antivirals. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Enosi Tuipulotu, Daniel. “Norovirus antiviral discovery: host-modulators and direct-acting antivirals.” 2018. Doctoral Dissertation, University of New South Wales. Accessed October 19, 2019. http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true.

MLA Handbook (7th Edition):

Enosi Tuipulotu, Daniel. “Norovirus antiviral discovery: host-modulators and direct-acting antivirals.” 2018. Web. 19 Oct 2019.

Vancouver:

Enosi Tuipulotu D. Norovirus antiviral discovery: host-modulators and direct-acting antivirals. [Internet] [Doctoral dissertation]. University of New South Wales; 2018. [cited 2019 Oct 19]. Available from: http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true.

Council of Science Editors:

Enosi Tuipulotu D. Norovirus antiviral discovery: host-modulators and direct-acting antivirals. [Doctoral Dissertation]. University of New South Wales; 2018. Available from: http://handle.unsw.edu.au/1959.4/62681 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:58917/SOURCE02?view=true


University of New South Wales

3. Netzler, Natalie. Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae.

Degree: Biotechnology & Biomolecular Sciences, 2019, University of New South Wales

 Human pathogens from the Caliciviridae and Hepeviridae families impose a significant health and economic burden on our global society. Despite the substantial toll caused by… (more)

Subjects/Keywords: Norovirus; Antivirals; Broad-spectrum antivirals; Hepatitis E virus; Caliciviridae; Hepeviridae

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Netzler, N. (2019). Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Netzler, Natalie. “Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae.” 2019. Doctoral Dissertation, University of New South Wales. Accessed October 19, 2019. http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true.

MLA Handbook (7th Edition):

Netzler, Natalie. “Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae.” 2019. Web. 19 Oct 2019.

Vancouver:

Netzler N. Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae. [Internet] [Doctoral dissertation]. University of New South Wales; 2019. [cited 2019 Oct 19]. Available from: http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true.

Council of Science Editors:

Netzler N. Broad-spectrum antivirals targeting viruses from the caliciviridae and hepeviridae. [Doctoral Dissertation]. University of New South Wales; 2019. Available from: http://handle.unsw.edu.au/1959.4/62685 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:59105/SOURCE02?view=true


Virginia Commonwealth University

4. Bhave, Sukhada. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.

Degree: MS, Microbiology & Immunology, 2012, Virginia Commonwealth University

 Cytomegalovirus (CMV) infections remain a significant problem in congenitally infected infants and immunocompromised individuals. Modest antiviral activities of currently approved drugs coupled with dose-limiting toxicities… (more)

Subjects/Keywords: cytomegalovirus; antivirals; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bhave, S. (2012). INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. (Thesis). Virginia Commonwealth University. Retrieved from https://scholarscompass.vcu.edu/etd/2838

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bhave, Sukhada. “INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.” 2012. Thesis, Virginia Commonwealth University. Accessed October 19, 2019. https://scholarscompass.vcu.edu/etd/2838.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bhave, Sukhada. “INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS.” 2012. Web. 19 Oct 2019.

Vancouver:

Bhave S. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. [Internet] [Thesis]. Virginia Commonwealth University; 2012. [cited 2019 Oct 19]. Available from: https://scholarscompass.vcu.edu/etd/2838.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bhave S. INVESTIGATING SYNERGY BETWEEN RIBONUCLEOTIDE REDUCTASE INHIBITORS AND CMV ANTIVIRALS. [Thesis]. Virginia Commonwealth University; 2012. Available from: https://scholarscompass.vcu.edu/etd/2838

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Edinburgh

5. Imhof, Ingrid. Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6.

Degree: PhD, 2010, University of Edinburgh

 The development of specific antiviral drugs directly targeting the hepatitis C virus (HCV) is clinically important, as the current standard interferon/ribavirin combination treatment is only… (more)

Subjects/Keywords: 615; HCV; hepatitis C virus; antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Imhof, I. (2010). Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6. (Doctoral Dissertation). University of Edinburgh. Retrieved from http://hdl.handle.net/1842/6207

Chicago Manual of Style (16th Edition):

Imhof, Ingrid. “Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6.” 2010. Doctoral Dissertation, University of Edinburgh. Accessed October 19, 2019. http://hdl.handle.net/1842/6207.

MLA Handbook (7th Edition):

Imhof, Ingrid. “Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6.” 2010. Web. 19 Oct 2019.

Vancouver:

Imhof I. Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6. [Internet] [Doctoral dissertation]. University of Edinburgh; 2010. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/1842/6207.

Council of Science Editors:

Imhof I. Development of an intra- and intergenotypic HCV cell culture method to phenotype and assess antiviral susceptibilities and resistance development of HCV NS3 protease genes from HCV genotypes 1-6. [Doctoral Dissertation]. University of Edinburgh; 2010. Available from: http://hdl.handle.net/1842/6207

6. Hadpech, Sudarat. Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation.

Degree: Docteur es, Biologie, 2017, Lyon; Mahāwitthayālai Chīang Mai

Au cours de notre programme de thèse, nous avons isolé et caractérisé des molécules protéiques à activité antivirale intracellulaire dirigée contre le VIH-1. Ces protéines,… (more)

Subjects/Keywords: Antivirals; VIH-1; Protéines à motifs répétés; AlphaRep; Antivirals; HIV-1; Repeat proteins; AlphaRep; 572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hadpech, S. (2017). Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation. (Doctoral Dissertation). Lyon; Mahāwitthayālai Chīang Mai. Retrieved from http://www.theses.fr/2017LYSE1139

Chicago Manual of Style (16th Edition):

Hadpech, Sudarat. “Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation.” 2017. Doctoral Dissertation, Lyon; Mahāwitthayālai Chīang Mai. Accessed October 19, 2019. http://www.theses.fr/2017LYSE1139.

MLA Handbook (7th Edition):

Hadpech, Sudarat. “Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation.” 2017. Web. 19 Oct 2019.

Vancouver:

Hadpech S. Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation. [Internet] [Doctoral dissertation]. Lyon; Mahāwitthayālai Chīang Mai; 2017. [cited 2019 Oct 19]. Available from: http://www.theses.fr/2017LYSE1139.

Council of Science Editors:

Hadpech S. Nouveaux agents antiviraux dérivés de protéines cellulaires à motifs répétés et ciblant l’assemblage du VIH : Application of Alpha-Repeat Proteins as Antiviral Molecules Against HIV-1 Targeting Viral Assembly or Maturation. [Doctoral Dissertation]. Lyon; Mahāwitthayālai Chīang Mai; 2017. Available from: http://www.theses.fr/2017LYSE1139


Universitat Pompeu Fabra

7. Fleta Soriano, Eric, 1983-. Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs.

Degree: Departament de Ciències Experimentals i de la Salut, 2015, Universitat Pompeu Fabra

 Cientos de factores del huésped relacionados con infecciones virales por VIH, hepatitis C, dengue o virus del Nilo occidental han sido identificados. Como muchos de… (more)

Subjects/Keywords: Broad-spectrum antivirals; Host-actings antivirals; HIV; Soraphen A; Ratjadone A; VIH; Antiiviral amplio aspectro; Antiviral contra hospedador; 578

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fleta Soriano, Eric, 1. (2015). Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs. (Thesis). Universitat Pompeu Fabra. Retrieved from http://hdl.handle.net/10803/402212

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fleta Soriano, Eric, 1983-. “Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs.” 2015. Thesis, Universitat Pompeu Fabra. Accessed October 19, 2019. http://hdl.handle.net/10803/402212.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fleta Soriano, Eric, 1983-. “Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs.” 2015. Web. 19 Oct 2019.

Vancouver:

Fleta Soriano, Eric 1. Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs. [Internet] [Thesis]. Universitat Pompeu Fabra; 2015. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/10803/402212.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fleta Soriano, Eric 1. Broad-spectrum host-acting antivirals: identification and characterization of anti-HIV drugs. [Thesis]. Universitat Pompeu Fabra; 2015. Available from: http://hdl.handle.net/10803/402212

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

8. Jesteadt, Eric Matthew Neff. USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS.

Degree: 2014, Johns Hopkins University

 Influenza is a global public health burden, producing seasonal epidemics with 3-5 million severe cases and 250,000 to 500,000 deaths each year. In addition to… (more)

Subjects/Keywords: Influenza; RNAi; antivirals; therapeutics

antivirals that can be used to control an infection. These are the neuraminidase inhibitors and the… …second class of antivirals, the adamantanes, includes amantadine and rimantadine (32)… …antivirals useless. RNA interference and the basics of RNAi therapeutics An attractive alternative… …to antivirals is the development of treatments based on the mechanism of RNA interference… …vectors expressing shRNAs (50). RNA interference-based antivirals against Respiratory… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jesteadt, E. M. N. (2014). USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/37266

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Jesteadt, Eric Matthew Neff. “USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS.” 2014. Thesis, Johns Hopkins University. Accessed October 19, 2019. http://jhir.library.jhu.edu/handle/1774.2/37266.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Jesteadt, Eric Matthew Neff. “USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS.” 2014. Web. 19 Oct 2019.

Vancouver:

Jesteadt EMN. USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2019 Oct 19]. Available from: http://jhir.library.jhu.edu/handle/1774.2/37266.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Jesteadt EMN. USING THE INFLUENZA POLYMERASE 5'-ENDONUCLEASE ACTIVITY TO DEVELOP NOVEL siRNA THERAPEUTICS. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/37266

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


EPFL

9. Müller, Marie. Broad-spectrum Antiviral Nanoparticles: a morphological CryoEM Study on the Interaction of Nanoparticles and Viruses.

Degree: 2017, EPFL

 Viral infections affect millions of people every year, yet broad-spectrum virucidal therapies are not available. Antiviral substances in current use act on specific viral mechanisms… (more)

Subjects/Keywords: Nanoparticles; Viruses; CryoEM; CryoET; broad-spectrum antivirals; virustatic; virucidal; HSPG; HSV

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Müller, M. (2017). Broad-spectrum Antiviral Nanoparticles: a morphological CryoEM Study on the Interaction of Nanoparticles and Viruses. (Thesis). EPFL. Retrieved from http://infoscience.epfl.ch/record/230033

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Müller, Marie. “Broad-spectrum Antiviral Nanoparticles: a morphological CryoEM Study on the Interaction of Nanoparticles and Viruses.” 2017. Thesis, EPFL. Accessed October 19, 2019. http://infoscience.epfl.ch/record/230033.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Müller, Marie. “Broad-spectrum Antiviral Nanoparticles: a morphological CryoEM Study on the Interaction of Nanoparticles and Viruses.” 2017. Web. 19 Oct 2019.

Vancouver:

Müller M. Broad-spectrum Antiviral Nanoparticles: a morphological CryoEM Study on the Interaction of Nanoparticles and Viruses. [Internet] [Thesis]. EPFL; 2017. [cited 2019 Oct 19]. Available from: http://infoscience.epfl.ch/record/230033.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Müller M. Broad-spectrum Antiviral Nanoparticles: a morphological CryoEM Study on the Interaction of Nanoparticles and Viruses. [Thesis]. EPFL; 2017. Available from: http://infoscience.epfl.ch/record/230033

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Sydney

10. Swaminathan, Kavya. Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry .

Degree: 2013, University of Sydney

 A novel matrix assisted laser desorption ionization (MALDI) mass spectrometry based approach to study the binding of inhibitors to the influenza virus neuraminidase is described.… (more)

Subjects/Keywords: Influenza; Antivirals; MassTrees; Anthocyanin; Drug resistance; Mass spectrometry

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Swaminathan, K. (2013). Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/10220

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Swaminathan, Kavya. “Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry .” 2013. Thesis, University of Sydney. Accessed October 19, 2019. http://hdl.handle.net/2123/10220.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Swaminathan, Kavya. “Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry .” 2013. Web. 19 Oct 2019.

Vancouver:

Swaminathan K. Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry . [Internet] [Thesis]. University of Sydney; 2013. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/2123/10220.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Swaminathan K. Novel anthocyanin inhibitors to influenza neuraminidase and monitioring antiviral resistance by mass spectrometry . [Thesis]. University of Sydney; 2013. Available from: http://hdl.handle.net/2123/10220

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Esteban, Juan Ignacio. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.

Degree: 2018, American Society for Microbiology

Subjects/Keywords: Hepatitis C; Antivirals; HCV; Medicina

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Esteban, J. I. (2018). High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. (Thesis). American Society for Microbiology. Retrieved from http://hdl.handle.net/10486/672182

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Esteban, Juan Ignacio. “High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.” 2018. Thesis, American Society for Microbiology. Accessed October 19, 2019. http://hdl.handle.net/10486/672182.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Esteban, Juan Ignacio. “High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.” 2018. Web. 19 Oct 2019.

Vancouver:

Esteban JI. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. [Internet] [Thesis]. American Society for Microbiology; 2018. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/10486/672182.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Esteban JI. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. [Thesis]. American Society for Microbiology; 2018. Available from: http://hdl.handle.net/10486/672182

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Queen Mary, University of London

12. Wing, Peter Alexander Cornelius. Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals.

Degree: PhD, 2018, Queen Mary, University of London

 Sofosbuvir is a uridine based nucleotide inhibitor of the hepatitis C viral (HCV) polymerase that is the backbone of many treatment regimens. In combination with… (more)

Subjects/Keywords: HEPATITIS C VIRUS; Antivirals; sofosbuvir; Genotype 3 HCV

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wing, P. A. C. (2018). Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210

Chicago Manual of Style (16th Edition):

Wing, Peter Alexander Cornelius. “Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals.” 2018. Doctoral Dissertation, Queen Mary, University of London. Accessed October 19, 2019. http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210.

MLA Handbook (7th Edition):

Wing, Peter Alexander Cornelius. “Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals.” 2018. Web. 19 Oct 2019.

Vancouver:

Wing PAC. Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2018. [cited 2019 Oct 19]. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210.

Council of Science Editors:

Wing PAC. Reduced sensitivity of Genotype 3 hepatitis C virus to direct acting antivirals. [Doctoral Dissertation]. Queen Mary, University of London; 2018. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/44044 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766210


Loyola University Chicago

13. Banach, Bridget. A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism.

Degree: PhD, Microbiology and Immunology, 2012, Loyola University Chicago

  Acute respiratory tract infections in humans are responsible for significant morbidity and mortality especially in children, elderly, and the immunocompromised. Virus infection is the… (more)

Subjects/Keywords: Antivirals; HCoV-NL63; human airway epithelium; immunofluorescence; PLP2; TEM; Virology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Banach, B. (2012). A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism. (Doctoral Dissertation). Loyola University Chicago. Retrieved from https://ecommons.luc.edu/luc_diss_restrict/12

Chicago Manual of Style (16th Edition):

Banach, Bridget. “A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism.” 2012. Doctoral Dissertation, Loyola University Chicago. Accessed October 19, 2019. https://ecommons.luc.edu/luc_diss_restrict/12.

MLA Handbook (7th Edition):

Banach, Bridget. “A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism.” 2012. Web. 19 Oct 2019.

Vancouver:

Banach B. A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism. [Internet] [Doctoral dissertation]. Loyola University Chicago; 2012. [cited 2019 Oct 19]. Available from: https://ecommons.luc.edu/luc_diss_restrict/12.

Council of Science Editors:

Banach B. A Study of Human Coronavirus NL63: Characterization of Virus Replication, Targeting of Papain-Like Protease 2 by Antivirals and Probing Virus Mediated Innate Immune Antagonism. [Doctoral Dissertation]. Loyola University Chicago; 2012. Available from: https://ecommons.luc.edu/luc_diss_restrict/12


University of New South Wales

14. Eltahla, Auda Abdelsalam. Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design.

Degree: Biotechnology & Biomolecular Sciences, 2014, University of New South Wales

 The hepatitis C virus (HCV) and norovirus (NoV) are significant human pathogens posing a substantial health and economic burden in both developing and developed countries.… (more)

Subjects/Keywords: RNA-dependent RNA polymerase; Hepatitis C virus; Norovirus; Antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Eltahla, A. A. (2014). Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Eltahla, Auda Abdelsalam. “Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design.” 2014. Doctoral Dissertation, University of New South Wales. Accessed October 19, 2019. http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true.

MLA Handbook (7th Edition):

Eltahla, Auda Abdelsalam. “Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design.” 2014. Web. 19 Oct 2019.

Vancouver:

Eltahla AA. Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design. [Internet] [Doctoral dissertation]. University of New South Wales; 2014. [cited 2019 Oct 19]. Available from: http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true.

Council of Science Editors:

Eltahla AA. Non-nucleoside inhibitors of viral RNA polymerases; scaffolds for rational drug design. [Doctoral Dissertation]. University of New South Wales; 2014. Available from: http://handle.unsw.edu.au/1959.4/53565 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:12262/SOURCE02?view=true


University of Manitoba

15. Cook, Bradley William Michael. Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus.

Degree: Microbiology, 2015, University of Manitoba

 Kyasanur Forest disease virus (KFDV) of the Flaviviridae virus family has caused seasonal infections and periodic outbreaks in Karnataka, India. First identified in 1957, KFDV… (more)

Subjects/Keywords: Flavivirus; Tick-borne flavivirus; Interferon; Molecular biology; Antivirals; Hemorrhagic fever virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cook, B. W. M. (2015). Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus. (Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/30913

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Cook, Bradley William Michael. “Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus.” 2015. Thesis, University of Manitoba. Accessed October 19, 2019. http://hdl.handle.net/1993/30913.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Cook, Bradley William Michael. “Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus.” 2015. Web. 19 Oct 2019.

Vancouver:

Cook BWM. Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus. [Internet] [Thesis]. University of Manitoba; 2015. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/1993/30913.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Cook BWM. Developing Antiviral Platforms And Assessing Interferon Against Kyasanur Forest Disease Virus. [Thesis]. University of Manitoba; 2015. Available from: http://hdl.handle.net/1993/30913

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


The Ohio State University

16. Meister, Gabriel T. Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus.

Degree: PhD, Pathology, 2005, The Ohio State University

 Leflunomide is an experimental immunosuppressive agent that has shown efficacy as an antiviral agent against human cytomegalovirus (HCMV) and polyomavirus strain BK (BKV). An antiviral… (more)

Subjects/Keywords: HCMV; cytomegalovirus; polyomavirus; antivirals; viral replication

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Meister, G. T. (2005). Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus. (Doctoral Dissertation). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519

Chicago Manual of Style (16th Edition):

Meister, Gabriel T. “Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus.” 2005. Doctoral Dissertation, The Ohio State University. Accessed October 19, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519.

MLA Handbook (7th Edition):

Meister, Gabriel T. “Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus.” 2005. Web. 19 Oct 2019.

Vancouver:

Meister GT. Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus. [Internet] [Doctoral dissertation]. The Ohio State University; 2005. [cited 2019 Oct 19]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519.

Council of Science Editors:

Meister GT. Antiviral mechanism(s) of the experimental immunosuppressive agent leflunomide against human cytomegalovirus and polyomavirus. [Doctoral Dissertation]. The Ohio State University; 2005. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1111428519

17. Chulick, John P. The Effects of Natural Variation in Human RIG-Like Receptors on RNA Binding Affinity.

Degree: 2017, University of Florida

 Within the innate immune system are the RIG-like receptors (RLRs), RIG-I and MDA5. RLRs identify viral RNAs within the cytoplasm of the cell and initiate… (more)

Subjects/Keywords: Amino acids; Antivirals; Hydrogen bonds; Ligands; Modeling; Pathogens; Population parameters; Receptors; RNA; Viral RNA

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chulick, J. P. (2017). The Effects of Natural Variation in Human RIG-Like Receptors on RNA Binding Affinity. (Thesis). University of Florida. Retrieved from http://ufdc.ufl.edu/AA00057907

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chulick, John P. “The Effects of Natural Variation in Human RIG-Like Receptors on RNA Binding Affinity.” 2017. Thesis, University of Florida. Accessed October 19, 2019. http://ufdc.ufl.edu/AA00057907.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chulick, John P. “The Effects of Natural Variation in Human RIG-Like Receptors on RNA Binding Affinity.” 2017. Web. 19 Oct 2019.

Vancouver:

Chulick JP. The Effects of Natural Variation in Human RIG-Like Receptors on RNA Binding Affinity. [Internet] [Thesis]. University of Florida; 2017. [cited 2019 Oct 19]. Available from: http://ufdc.ufl.edu/AA00057907.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chulick JP. The Effects of Natural Variation in Human RIG-Like Receptors on RNA Binding Affinity. [Thesis]. University of Florida; 2017. Available from: http://ufdc.ufl.edu/AA00057907

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Richard, Mathilde. Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin.

Degree: Docteur es, Virologie, 2010, Université Claude Bernard – Lyon I

Chaque année, les épidémies de grippe, dont les principaux agents étiologiques sont les virus influenza de type A, ont un impact considérable sur la population… (more)

Subjects/Keywords: Influenza; Neuraminidase; Antiviraux; Résistance; Balance fonctionnelle; Influenza; Neuraminidase; Antivirals; Resistance; Functionnal balance; 616.203

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Richard, M. (2010). Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2010LYO10323

Chicago Manual of Style (16th Edition):

Richard, Mathilde. “Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin.” 2010. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed October 19, 2019. http://www.theses.fr/2010LYO10323.

MLA Handbook (7th Edition):

Richard, Mathilde. “Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin.” 2010. Web. 19 Oct 2019.

Vancouver:

Richard M. Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2010. [cited 2019 Oct 19]. Available from: http://www.theses.fr/2010LYO10323.

Council of Science Editors:

Richard M. Diversité des mécanismes de résistance aux inhibiteurs de la neuraminidase des virus influenza A : implications de résidus conservés dans le site actif de la neuraminidase et de la balance fonctionnelle entre la neuraminidase et l’hémagglutinine : Diversity of resistance mechanisms to influenza A neuraminidase inhibitors : implication of conserved residues in the neuraminidase active site and of the functional balance between the neuraminidase and the hemagglutinin. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2010. Available from: http://www.theses.fr/2010LYO10323

19. Foca, Adrien. Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B.

Degree: Docteur es, Virologie et cancérologie, 2018, Lyon

 Dans les régions de fortes endémicités, 70-80% des carcinomes hépatocellulaires sont induits par le VHB. Bien qu’un vaccin prophylactique très efficace existe, il n’est d’aucune… (more)

Subjects/Keywords: PLK1; ARN interférents; Hépatite B; Carcinome hépatocellulaire; Antiviraux; PLK1; SiRNA; HBV; HCC; Antivirals HTA; 570

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Foca, A. (2018). Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2018LYSE1310

Chicago Manual of Style (16th Edition):

Foca, Adrien. “Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B.” 2018. Doctoral Dissertation, Lyon. Accessed October 19, 2019. http://www.theses.fr/2018LYSE1310.

MLA Handbook (7th Edition):

Foca, Adrien. “Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B.” 2018. Web. 19 Oct 2019.

Vancouver:

Foca A. Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B. [Internet] [Doctoral dissertation]. Lyon; 2018. [cited 2019 Oct 19]. Available from: http://www.theses.fr/2018LYSE1310.

Council of Science Editors:

Foca A. Identification of PLK1 as a proviral factor for the hepatitis B virus replication : A possible target for antiviral and anticancerous drug development : Développement et utilisation d'ARN interférents dirigés contre PLK1 dans le cadre d'une infection chronique par le virus de l'hépatite B. [Doctoral Dissertation]. Lyon; 2018. Available from: http://www.theses.fr/2018LYSE1310


Boston University

20. Buczek, Magdalena Marta. Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital.

Degree: MS, Medical Sciences, 2017, Boston University

 INTRODUCTION: Mortality associated with hepatitis C virus (HCV) infection is increasing, yet only a small percentage of HCV-infected individuals are aware of their infections, complete… (more)

Subjects/Keywords: Medicine; Direct-acting antivirals; Hepatitis C virus; Multidisciplinary team; Pharmacy; Primary care; Social work

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Buczek, M. M. (2017). Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/23754

Chicago Manual of Style (16th Edition):

Buczek, Magdalena Marta. “Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital.” 2017. Masters Thesis, Boston University. Accessed October 19, 2019. http://hdl.handle.net/2144/23754.

MLA Handbook (7th Edition):

Buczek, Magdalena Marta. “Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital.” 2017. Web. 19 Oct 2019.

Vancouver:

Buczek MM. Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital. [Internet] [Masters thesis]. Boston University; 2017. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/2144/23754.

Council of Science Editors:

Buczek MM. Qualitative study of a primary care-based hepatitis C treatment program at a safety-net hospital. [Masters Thesis]. Boston University; 2017. Available from: http://hdl.handle.net/2144/23754

21. Aillot, Ludovic. Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV.

Degree: Docteur es, Infectiologie, 2018, Lyon

 Le virus de l'hépatite B (HBV) infecte chroniquement près de 240 millions d'individus dans le monde. L'infection chronique par HBV est un souci de santé… (more)

Subjects/Keywords: HBV; Toll-like Récepteurs; Antiviraux; Immunité innée; HBV; Toll-like Receptors; Antivirals; Innate immunity; 572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aillot, L. (2018). Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2018LYSE1139

Chicago Manual of Style (16th Edition):

Aillot, Ludovic. “Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV.” 2018. Doctoral Dissertation, Lyon. Accessed October 19, 2019. http://www.theses.fr/2018LYSE1139.

MLA Handbook (7th Edition):

Aillot, Ludovic. “Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV.” 2018. Web. 19 Oct 2019.

Vancouver:

Aillot L. Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV. [Internet] [Doctoral dissertation]. Lyon; 2018. [cited 2019 Oct 19]. Available from: http://www.theses.fr/2018LYSE1139.

Council of Science Editors:

Aillot L. Effets antiviraux de l'agonisation des Toll-like Récepteurs dans les cellules du foie, une nouvelle stratégie immunothérapeutique dans la lutte contre HBV : Antiviral effects by Toll-like receptors agonisation in liver cells, a new immunotherapeuticstrategy in the fight against HBV. [Doctoral Dissertation]. Lyon; 2018. Available from: http://www.theses.fr/2018LYSE1139


University of California – San Francisco

22. Asher, Alice Kathleen. Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals.

Degree: Nursing, 2015, University of California – San Francisco

 Hepatitis C virus (HCV) infection affects millions of Americans at a high public health cost. Despite the availability of a curative treatment, a significant proportion… (more)

Subjects/Keywords: Nursing; clinicians; direct-acting antivirals; Hepatitis C treatment; People who inject drugs

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Asher, A. K. (2015). Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals. (Thesis). University of California – San Francisco. Retrieved from http://www.escholarship.org/uc/item/1cz9c2f6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Asher, Alice Kathleen. “Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals.” 2015. Thesis, University of California – San Francisco. Accessed October 19, 2019. http://www.escholarship.org/uc/item/1cz9c2f6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Asher, Alice Kathleen. “Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals.” 2015. Web. 19 Oct 2019.

Vancouver:

Asher AK. Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals. [Internet] [Thesis]. University of California – San Francisco; 2015. [cited 2019 Oct 19]. Available from: http://www.escholarship.org/uc/item/1cz9c2f6.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Asher AK. Hepatitis C virus treatment, people who inject drugs, and treatment barriers in the age of direct-acting antivirals. [Thesis]. University of California – San Francisco; 2015. Available from: http://www.escholarship.org/uc/item/1cz9c2f6

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

23. Sindac, Janice A. Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus.

Degree: PhD, Medicinal Chemistry, 2014, University of Michigan

 Arborviruses such as western equine encephalitis virus (WEEV) are capable of causing a wide range of diseases in humans. The CDC and NIAID consider WEEV… (more)

Subjects/Keywords: alphavirus; antivirals; Biological Chemistry; Science

…emphasizes the significance of this work, as there is a critical need to develop potent antivirals… …the CNS emphasizes the need for antivirals to prevent viral replication and neuroprotective… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sindac, J. A. (2014). Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/110326

Chicago Manual of Style (16th Edition):

Sindac, Janice A. “Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus.” 2014. Doctoral Dissertation, University of Michigan. Accessed October 19, 2019. http://hdl.handle.net/2027.42/110326.

MLA Handbook (7th Edition):

Sindac, Janice A. “Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus.” 2014. Web. 19 Oct 2019.

Vancouver:

Sindac JA. Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus. [Internet] [Doctoral dissertation]. University of Michigan; 2014. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/2027.42/110326.

Council of Science Editors:

Sindac JA. Development of Small Molecule Replication Inhibitors Against Western Equine Encephalitis Virus. [Doctoral Dissertation]. University of Michigan; 2014. Available from: http://hdl.handle.net/2027.42/110326


Université de Montréal

24. Dumoulin, Jeanne. L’allocation d’antiviraux dans un contexte de pandémie : vérification de critères auprès des professionnels de la santé pour le développement d’un cadre éthique .

Degree: 2010, Université de Montréal

 Cette étude a pour objectif d’évaluer la stratégie d’utilisation de critères de base, d’un point de vue éthique, dans l’allocation d’une quantité limitée d’antiviraux pour… (more)

Subjects/Keywords: Bioéthique; groupe de discussion; pandémie d’influenza; analyse qualitative; prophylaxie; Bioethics; antivirals; focus group; influenza pandemic; qualitative analysis; prophylaxis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dumoulin, J. (2010). L’allocation d’antiviraux dans un contexte de pandémie : vérification de critères auprès des professionnels de la santé pour le développement d’un cadre éthique . (Thesis). Université de Montréal. Retrieved from http://hdl.handle.net/1866/3627

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dumoulin, Jeanne. “L’allocation d’antiviraux dans un contexte de pandémie : vérification de critères auprès des professionnels de la santé pour le développement d’un cadre éthique .” 2010. Thesis, Université de Montréal. Accessed October 19, 2019. http://hdl.handle.net/1866/3627.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dumoulin, Jeanne. “L’allocation d’antiviraux dans un contexte de pandémie : vérification de critères auprès des professionnels de la santé pour le développement d’un cadre éthique .” 2010. Web. 19 Oct 2019.

Vancouver:

Dumoulin J. L’allocation d’antiviraux dans un contexte de pandémie : vérification de critères auprès des professionnels de la santé pour le développement d’un cadre éthique . [Internet] [Thesis]. Université de Montréal; 2010. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/1866/3627.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dumoulin J. L’allocation d’antiviraux dans un contexte de pandémie : vérification de critères auprès des professionnels de la santé pour le développement d’un cadre éthique . [Thesis]. Université de Montréal; 2010. Available from: http://hdl.handle.net/1866/3627

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Chicago

25. Sansone, Natasha D. Mathematical Modeling as a Tool to Elucidate HCV Infection Kinetics and Treatment Response.

Degree: 2017, University of Illinois – Chicago

 Hepatitis C virus (HCV) treatment options have advanced significantly during the course of this thesis work, however, there are still approximately 170 million people chronically… (more)

Subjects/Keywords: Virology; Kinetics; Viral Life Cycle; Mathematical Modeling; Predictive Models; Differential Equations; Pharmacokinetics; Drug Mechanism of Action; Direct Acting Antivirals

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sansone, N. D. (2017). Mathematical Modeling as a Tool to Elucidate HCV Infection Kinetics and Treatment Response. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/22187

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sansone, Natasha D. “Mathematical Modeling as a Tool to Elucidate HCV Infection Kinetics and Treatment Response.” 2017. Thesis, University of Illinois – Chicago. Accessed October 19, 2019. http://hdl.handle.net/10027/22187.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sansone, Natasha D. “Mathematical Modeling as a Tool to Elucidate HCV Infection Kinetics and Treatment Response.” 2017. Web. 19 Oct 2019.

Vancouver:

Sansone ND. Mathematical Modeling as a Tool to Elucidate HCV Infection Kinetics and Treatment Response. [Internet] [Thesis]. University of Illinois – Chicago; 2017. [cited 2019 Oct 19]. Available from: http://hdl.handle.net/10027/22187.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sansone ND. Mathematical Modeling as a Tool to Elucidate HCV Infection Kinetics and Treatment Response. [Thesis]. University of Illinois – Chicago; 2017. Available from: http://hdl.handle.net/10027/22187

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

26. Sahuc, Marie-Emmanuelle. Identification de composés naturels inhibant le virus de l’hépatite C : Identification of naturals compounds inhibiting hepatitis C virus.

Degree: Docteur es, Biologie cellulaire, 2017, Université Lille II – Droit et Santé

L’hépatite C est une maladie affectant aujourd’hui 170 millions d’individus dans le monde. Cette maladie est causée par le virus de l'hépatite C (VHC). Les… (more)

Subjects/Keywords: Flaviviridae; Hepacivirus; Hépatite C; Antiviraux naturels; Virologie; Thé vert; Anthocyanine; Catéchine; Hepatitis C; Green tea; Natural antivirals; Virology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sahuc, M. (2017). Identification de composés naturels inhibant le virus de l’hépatite C : Identification of naturals compounds inhibiting hepatitis C virus. (Doctoral Dissertation). Université Lille II – Droit et Santé. Retrieved from http://www.theses.fr/2017LIL2S056

Chicago Manual of Style (16th Edition):

Sahuc, Marie-Emmanuelle. “Identification de composés naturels inhibant le virus de l’hépatite C : Identification of naturals compounds inhibiting hepatitis C virus.” 2017. Doctoral Dissertation, Université Lille II – Droit et Santé. Accessed October 19, 2019. http://www.theses.fr/2017LIL2S056.

MLA Handbook (7th Edition):

Sahuc, Marie-Emmanuelle. “Identification de composés naturels inhibant le virus de l’hépatite C : Identification of naturals compounds inhibiting hepatitis C virus.” 2017. Web. 19 Oct 2019.

Vancouver:

Sahuc M. Identification de composés naturels inhibant le virus de l’hépatite C : Identification of naturals compounds inhibiting hepatitis C virus. [Internet] [Doctoral dissertation]. Université Lille II – Droit et Santé 2017. [cited 2019 Oct 19]. Available from: http://www.theses.fr/2017LIL2S056.

Council of Science Editors:

Sahuc M. Identification de composés naturels inhibant le virus de l’hépatite C : Identification of naturals compounds inhibiting hepatitis C virus. [Doctoral Dissertation]. Université Lille II – Droit et Santé 2017. Available from: http://www.theses.fr/2017LIL2S056


University of Florida

27. Shringarpure, Natalia. The Effect of the ATG8 Gene on the Antiviral Response in Drosophila Melanogaster.

Degree: 2015, University of Florida

 In this experiment, RNAi knockdown was implemented to test whether the ATG8 gene, previously implicated in the autophagy pathway, is used in the antiviral response… (more)

Subjects/Keywords: Antivirals; Complementary DNA; Correlations; Drosophila; Genetic mutation; Infections; Insulin; Nucleic acids; Polymerase chain reaction; RNA; ATG8; DCV; Drosophila; antiviral; autophagy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Shringarpure, N. (2015). The Effect of the ATG8 Gene on the Antiviral Response in Drosophila Melanogaster. (Thesis). University of Florida. Retrieved from http://ufdc.ufl.edu/AA00037457

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Shringarpure, Natalia. “The Effect of the ATG8 Gene on the Antiviral Response in Drosophila Melanogaster.” 2015. Thesis, University of Florida. Accessed October 19, 2019. http://ufdc.ufl.edu/AA00037457.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Shringarpure, Natalia. “The Effect of the ATG8 Gene on the Antiviral Response in Drosophila Melanogaster.” 2015. Web. 19 Oct 2019.

Vancouver:

Shringarpure N. The Effect of the ATG8 Gene on the Antiviral Response in Drosophila Melanogaster. [Internet] [Thesis]. University of Florida; 2015. [cited 2019 Oct 19]. Available from: http://ufdc.ufl.edu/AA00037457.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Shringarpure N. The Effect of the ATG8 Gene on the Antiviral Response in Drosophila Melanogaster. [Thesis]. University of Florida; 2015. Available from: http://ufdc.ufl.edu/AA00037457

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Florida

28. Mayper, Stephen. Characterization of M029 protein from Myxoma virus: A predicted inhibitor of cellular antiviral pathways.

Degree: 2011, University of Florida

 Myxoma virus (MYXV), a member of poxvirus has recently been implicated as a promising new oncolytic agent as it is able to productively infect multiple… (more)

Subjects/Keywords: Antibodies; Antivirals; Cell lines; DNA; Double stranded RNA; Infections; Monkeys; Proteins; Rabbits; Vaccinia virus; Cancer cells; Myxomatosis; Viral proteins; Viruses

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mayper, S. (2011). Characterization of M029 protein from Myxoma virus: A predicted inhibitor of cellular antiviral pathways. (Thesis). University of Florida. Retrieved from http://ufdc.ufl.edu/AA00057219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mayper, Stephen. “Characterization of M029 protein from Myxoma virus: A predicted inhibitor of cellular antiviral pathways.” 2011. Thesis, University of Florida. Accessed October 19, 2019. http://ufdc.ufl.edu/AA00057219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mayper, Stephen. “Characterization of M029 protein from Myxoma virus: A predicted inhibitor of cellular antiviral pathways.” 2011. Web. 19 Oct 2019.

Vancouver:

Mayper S. Characterization of M029 protein from Myxoma virus: A predicted inhibitor of cellular antiviral pathways. [Internet] [Thesis]. University of Florida; 2011. [cited 2019 Oct 19]. Available from: http://ufdc.ufl.edu/AA00057219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mayper S. Characterization of M029 protein from Myxoma virus: A predicted inhibitor of cellular antiviral pathways. [Thesis]. University of Florida; 2011. Available from: http://ufdc.ufl.edu/AA00057219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Florida

29. Hall, Elizabeth B. Development of a new method for examining interferon activity in biological samples.

Degree: MS, Veterinary Medical Sciences - Veterinary Medicine, 2012, University of Florida

 Interferons have the ability to prevent virus induced cell death. This activity has been used for decades as a biological assay to study interferon activity.… (more)

Subjects/Keywords: Antivirals; Cells; Cytokines; Diseases; Dosage; Infections; Interferons; Journalism; Receptors; Viral infections; antiviral  – assay  – cells  – interferon  – interferon-alpha  – interferon-tau  – mdbk

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hall, E. B. (2012). Development of a new method for examining interferon activity in biological samples. (Masters Thesis). University of Florida. Retrieved from http://ufdc.ufl.edu/UFE0044237

Chicago Manual of Style (16th Edition):

Hall, Elizabeth B. “Development of a new method for examining interferon activity in biological samples.” 2012. Masters Thesis, University of Florida. Accessed October 19, 2019. http://ufdc.ufl.edu/UFE0044237.

MLA Handbook (7th Edition):

Hall, Elizabeth B. “Development of a new method for examining interferon activity in biological samples.” 2012. Web. 19 Oct 2019.

Vancouver:

Hall EB. Development of a new method for examining interferon activity in biological samples. [Internet] [Masters thesis]. University of Florida; 2012. [cited 2019 Oct 19]. Available from: http://ufdc.ufl.edu/UFE0044237.

Council of Science Editors:

Hall EB. Development of a new method for examining interferon activity in biological samples. [Masters Thesis]. University of Florida; 2012. Available from: http://ufdc.ufl.edu/UFE0044237

30. Billioud, Gaëtan. Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants.

Degree: Docteur es, Biologie, 2011, Université Claude Bernard – Lyon I

Les traitements actuels contre le virus de l’hépatite B (VHB) combinent un ou plusieurs analogues de nucléos(t)ides qui inhibent directement la réplication virale en bloquant… (more)

Subjects/Keywords: VHB; Performances; Antiviraux; Analogues de nucléosides; Résistance; Sélection; Quasi-espèce; HBV; Fitness; Antivirals; Nucleoside analogs; Resistance; Selection; Quasi-species; 616.91

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Billioud, G. (2011). Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2011LYO10077

Chicago Manual of Style (16th Edition):

Billioud, Gaëtan. “Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants.” 2011. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed October 19, 2019. http://www.theses.fr/2011LYO10077.

MLA Handbook (7th Edition):

Billioud, Gaëtan. “Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants.” 2011. Web. 19 Oct 2019.

Vancouver:

Billioud G. Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2011. [cited 2019 Oct 19]. Available from: http://www.theses.fr/2011LYO10077.

Council of Science Editors:

Billioud G. Étude des performances de variants du virus de l’hépatite B : Fitness study of hepatitis B virus variants. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2011. Available from: http://www.theses.fr/2011LYO10077

[1] [2] [3]

.